Niagen Bioscience 公司
DE ˙ DB ˙ US1710774076
€2.70 ↓ -0.30 (-10.00%)
2026-06-04
分享價格
SecurityDE:OCD1 / Niagen Bioscience, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership3,871,619 shares
Latest Disclosed Value $ 17,073,839
BlackRock, Inc. reports 5.01% decrease in ownership of OCD1 / Niagen Bioscience, Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 3,871,619 shares of Niagen Bioscience, Inc. (DE:OCD1) valued at $13,550,666 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 4,075,709 shares of Niagen Bioscience, Inc.. This represents a change in shares of -5.01% during the quarter. The current value of the position is $10,453,371 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 3,871,619 -204,090 -5.01 17,074 -34.13 0.0000
2026-02-12 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 4,075,709 98,706 2.48 25,922 -30.14 0.0004
2025-11-12 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 3,977,003 120,679 3.13 37,105 -33.23 0.0006
2025-08-12 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 3,856,324 239,253 6.61 55,570 122.66 0.0011
2025-05-02 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 3,617,071 5,486 0.15 24,958 30.26 0.0005
2025-02-07 2024-12-31 13F CHROMADEX COM NEW 171077407 3,611,585 216,227 6.37 19,159 54.60 0.0004
2024-11-13 2024-09-30 13F CHROMADEX COM NEW 171077407 3,395,358 279,180 8.96 12,393 45.68 0.0003
2024-08-13 2024-06-30 13F CHROMADEX COM NEW 171077407 3,116,178 2,213,225 245.11 8,507 170.75 0.0002
2024-05-10 2024-03-31 13F CHROMADEX COM NEW 171077407 902,953 -1,739 -0.19 3,142 143.00 0.0001
2024-02-13 2023-12-31 13F CHROMADEX COM NEW 171077407 904,692 -2,809 -0.31 1,294 -2.34 0.0000
2023-11-13 2023-09-30 13F CHROMADEX COM NEW 171077407 907,501 -6,317 -0.69 1,325 -7.67 0.0000
2023-08-11 2023-06-30 13F CHROMADEX COM NEW 171077407 913,818 12,622 1.40 1,435 4.06 0.0000
2023-05-12 2023-03-31 13F CHROMADEX COM NEW 171077407 901,196 -82,793 -8.41 1,379 -16.64 0.0000
2023-02-13 2022-12-31 13F CHROMADEX COM NEW 171077407 983,989 943 0.10 1,653 36.72 0.0001
2022-11-14 2022-09-30 13F CHROMADEX COM NEW 171077407 983,046 -5,843 -0.59 1,209 -26.82 0.0000
2022-08-12 2022-06-30 13F CHROMADEX COM NEW 171077407 988,889 -2,164,820 -68.64 1,652 -78.71 0.0001
2022-05-12 2022-03-31 13F CHROMADEX COM NEW 171077407 3,153,709 -41,355 -1.29 7,758 -35.08 0.0002
2022-02-10 2021-12-31 13F CHROMADEX COM NEW 171077407 3,195,064 51,383 1.63 11,950 -39.38 0.0003
2021-11-09 2021-09-30 13F CHROMADEX COM NEW 171077407 3,143,681 25,074 0.80 19,712 -35.90 0.0006
2021-08-11 2021-06-30 13F CHROMADEX COM NEW 171077407 3,118,607 -53,733 -1.69 30,750 3.78 0.0009
2021-05-07 2021-03-31 13F CHROMADEX COM NEW 171077407 3,172,340 275,467 9.51 29,630 113.09 0.0009
2021-02-05 2020-12-31 13F CHROMADEX COM NEW 171077407 2,896,873 92,329 3.29 13,905 23.63 0.0004
2020-11-06 2020-09-30 13F CHROMADEX COM NEW 171077407 2,804,544 -23,044 -0.81 11,247 -13.34 0.0004
2020-08-14 2020-06-30 13F CHROMADEX COM NEW 171077407 2,827,588 359,728 14.58 12,979 61.31 0.0005
2020-05-01 2020-03-31 13F CHROMADEX COM NEW 171077407 2,467,860 -4,236 -0.17 8,046 -24.49 0.0004
2020-02-13 2019-12-31 13F CHROMADEX COM NEW 171077407 2,472,096 152,170 6.56 10,655 16.72 0.0004
2019-11-08 2019-09-30 13F CHROMADEX COM NEW 171077407 2,319,926 81,272 3.63 9,129 -12.31 0.0004
2019-08-22 2019-06-30 13F/A-1 CHROMADEX COM NEW 171077407 2,238,654 298,126 15.36 10,410 28.03 0.0004
2019-08-13 2019-06-30 13F CHROMADEX COM NEW 171077407 2,238,654 298,126 10,410
2019-05-09 2019-03-31 13F CHROMADEX COM NEW 171077407 1,940,528 26,610 1.39 8,131 23.85 0.0004
2019-02-08 2018-12-31 13F CHROMADEX COM NEW 171077407 1,913,918 485 0.03 6,565 -20.03 0.0003
2018-11-09 2018-09-30 13F CHROMADEX COM NEW 171077407 1,913,433 28,817 1.53 8,209 17.41 0.0004
2018-08-09 2018-06-30 13F CHROMADEX COM NEW 171077407 1,884,616 1,775,638 1,629.35 6,992 1,426.64 0.0003
2018-05-09 2018-03-31 13F CHROMADEX COM NEW 171077407 108,978 -2,229 -2.00 458 -29.97 0.0000
2018-02-09 2017-12-31 13F CHROMADEX COM NEW 171077407 111,207 9,917 9.79 654 50.00 0.0000
2017-11-14 2017-09-30 13F CHROMADEX COM NEW 171077407 101,290 4,333 4.47 436 17.84 0.0000
2017-08-10 2017-06-30 13F CHROMADEX COM NEW 171077407 96,957 -1,119,292 -92.03 370 -88.69 0.0000
2017-05-12 2017-03-31 13F CHROMADEX COM NEW 171077407 1,216,249 1,215,257 122,505.75 3,272 108,966.67 0.0002
2017-02-10 2016-12-31 13F CHROMADEX COM NEW 171077407 992 0 0.00 3 0.00 0.0000
2016-11-08 2016-09-30 13F CHROMADEX COM NEW 171077407 992 0 0.00 3 -25.00 0.0000
2016-08-10 2016-06-30 13F CHROMADEX COM NEW 171077407 992 992 4 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.